Daxor (DXR)

• Market cap: $35.9M
• 1 day: -1.20%
• 5 days: -5.96%
• 1 month: -7.03%
• 3 months: -12.82%
• 6 months: -18.84%
• Year to date: -1.85%
• 1 year: -22.89%
• 5 years: -47.30%
• 10 years: -8.74%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

Employees: 750

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

7% more capital invested

Capital invested by funds: $757K [Q3] → $811K (+$54.8K) [Q4]

0.36% more ownership

Funds ownership: 1.8% [Q3] → 2.16% (+0.36%) [Q4]

0% more funds holding

Funds holding: 9 [Q3] → 9 (+0) [Q4]

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $25 237% upside
• Avg. target: $25 237% upside
• High target: $25 237% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Ascendiant Capital Edward Woo 27% 1-year accuracy 19 / 70 met price target

237% upside $25

Buy Maintained

17 Mar 2025